Biomnis Joins Eurofins Scientific
Biomnis is proud to announce that we have become the newest member of the Eurofins Scientific global network of laboratories.
Eurofins Scientific is a French biotechnology group founded in Nantes in 1987 and is a global leader in food, environmental, genomics and discovery pharmacology. Following the acquisitions of Viracor, Boston Heart, Emory Genetic Lab and Diatherix in the United States and Nihon Soken in Japan, Eurofins is becoming one of the key emerging players in the field of specialty medical diagnostic testing. Biomnis will enable the Eurofins Group to deploy a technological and scientific know-how on a solid European platform enlarging its portfolio of specialised and innovative tests while reinforcing its global presence.
This acquisition is a natural fit as Eurofins and Biomnis share a vision of excellence and ongoing commitment to innovation for the benefit of all those we serve. As this new chapter opens in the Biomnis story, I would like to sincerely thank you for the confidence you place in us each and every day. I would like to reaffirm our commitment to work in partnership with you to support the evolution and needs of your organisation and to reassert our common goal: to offer all patients treatment that is among the best in the world.
For additional information regarding this announcement please click here to view the official Eurofins press release.
If you have any questions regarding this announcement please do not hesitate to contact your account manager or our commercial department on (01) 295 8545 or sales@biomnis.ie.
Kind regards,
John O’Sullivan
Managing Director
Biomnis Ireland
